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Abstract
Mesenchymal stem cells (MSCs) and pericyte progenitors (PPs) are both perivascular cells with similar multipotential
properties regardless of tissue of origin. We compared the phenotype and function of the 2 cell types derived from the
same bone-marrow samples but expanded in their respective media – pericyte conditions (endothelial cell growth medium
2 [EGM-2]) for PPs and standard medium (mesenchymal stem cell medium [MSM]) for MSCs. After 3 weeks of culture,
whatever the expansion medium, all cells showed similar characteristics (MSC markers and adipo-osteo-chondroblastic
differentiation potential), although neuronal potential was greater in EGM-2– than MSM-cultured cells. As compared with
MSM-cultured MSCs, EGM-2–cultured PPs showed higher expression of the pericyte-specific antigen 3G5 than a-smooth
muscle actin. In addition, EGM-2–cultured PPs showed an immature phenotype, with upregulation of stemness OCT4 and
SOX2 proteins and downregulation of markers of osteoblastic, chondroblastic, adipocytic and vascular smooth muscle
lineages. Despite having less effective in vitro immunosuppression capacities than standard MSCs, EGM-2–cultured PPs had
higher engraftment potentials when combined with biomaterials heterotopically-transplanted in Nude mice. Furthermore,
these engrafted cells generated more collagen matrix and were preferentially perivascular or lined trabeculae as compared
with MSM-cultured MSCs. In conclusion, EGM-2–cultured PPs are highly immature cells with increased plasticity and
engraftment potential.
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Introduction
Mesenchymal stem cells (MSCs) (also called multipotent
mesenchymal stromal cells) are tissue-resident multipotential cells
that give rise to bone cells, adipocytes, smooth muscle (SM) cells
and hematopoietic-supportive stromal cells [1,2,3,4]. They have
been identified in several tissues, including bone marrow (BM),
dental pulp, adipose tissue and umbilical cord blood. Such cells are
selected by their capacity to adhere to plastic culture flasks and
expand through fibroblastic colonies (colony formation unit
fibroblasts [CFU-fs]) within media containing at least 10% fetal
bovine serum (FBS) [5]. However, this ex vivo expansion protocol
hides their true nature, which explains the growing number of
works seeking to describe them directly in vivo in their native forms.
Native BM-MSCs express surface markers such as STRO-1,
CD49a, CD73, CD146 and CD271, which led researchers to
observe them mainly at the abluminal position of vessels
[5,6,7,8,9]. Indeed, non-hematopoietic CD146+ cells, capable of
self-renewal and supporting hematopoiesis, were identified as
perivascular cells [8]. However, pericytes are also defined as
populations of cells, including all perivascular cells, with similar
morphologic capacity (multi-branched cells) to directly interact
with endothelial cells and have common markers and properties of
vascular smooth muscle cells (VSMCs; induction of contractive
acto-myosine proteins) [6]. Pericytes are also multipotent cells
capable of generating adipocytes, osteoblasts and chondrocytes
[7,8]. They can be characterized by nestin, aminopeptidase N
(CD13), 3G5 antigen and NG2, all also described in BM-MSCs
[9,10,11,12,13]. Hence, whatever their origin, BM or adipose
tissue, MSCs were recently classified as pericytic cells, even if all
pericytes are not MSCs [11]. Because of the close similarities with
pericytes, MSCs could be at the forefront of organogenesis and
tissue regeneration. For instance, recent data in mice showed that
cells located at the pericytic position and at the front of invading
vessels could form bone during endochondral mechanisms of
skeletogenesis or after injury [14]. However, no studies have
compared pericytes and MSCs from the same BM samples.
Here, we investigated the similarities between and MSC
behavior and properties in MSCs and pericytic cells cultured in
PLOS ONE | www.plosone.org 1 November 2012 | Volume 7 | Issue 11 | e48648
standard MSC medium (MSM) or endothelial cell growth medium
2 (EGM-2) for pericyte expansion, respectively. Cultured BM-
derived pericytic cells showed progenitor/stem cell properties,
with higher plasticity and immaturity state than standard MSCs.
Materials and Methods
Cells
We collected adult human BM samples from healthy volunteers
undergoing orthopedic surgery. The study followed the ethical
guidelines of the University Hospital of Tours (Tours, France) and
was approved by the ethics committee Comite´ de protection des
personnes (Tours - Re´gion Centre [Ouest-1]). Patients gave their
written informed consent for use of samples. For each donor, BM
mononuclear cells were plated in 1) MSM, consisting of minimum
essential medium supplemented with 10% FBS (Stem-Cell
Technologies, Vancouver, BC, Canada) and 1% penicillin/
streptomycin (Invitrogen, Paisley, UK); or 2) EGM-2 (PromoCell
GmbH, Heidelberg, Germany). On day 10, cells at 80%
confluence were split and expanded (passage 1). We used cells at
passage 1 or 2 from at least 3 different donors for all studies.
Peripheral blood mononuclear cells (PBMCs) were obtained from
informed consent donors following ethical guidelines of Etablisse-
ment Franc¸ais du Sang Pyre´ne´es-Me´diterrane´e (Toulouse,
France).
MSC Multipotential Assay
MSC multipotentiality was determined after cell differentiation
into osteoblasts, chondroblasts, or adipocytic cells as previously
described [15,16]. Osteoblastic and chondroblastic differentiation
was revealed by staining with Alizarin red (Sigma-Aldrich, St.
Louis, MO, USA) and anti-COL2a1 (clone 6B3, Millipore,
Billerica, MA), respectively, and adipocytes by staining with
Nile-red oil solution (Sigma-Aldrich). Undifferentiated cells
cultured in expansion medium were a negative control. Revealing
neuronal potential was as previously described [17,18]. EGM-2–
or MSM-cultured cells were cultured in neuronal induction
medium, DMEM F12 with L-glutamine, 1% insulin-transferrine-
selenium, and 1% penicillin–streptomycin (Invitrogen). We added
Forskolin (40 mg/mL), nerve growth factor (50 ng/mL), NT3
(70 ng/mL), NT4 (100 ng/mL), and fibroblast growth factor 2
(125 ng/mL) (Euromedex, Souffelweyersheim, France). The cul-
ture medium was replaced every 3 to 4 days. Negative control cells
were maintained without any induction medium. After neuronal
differentiation, neurosphere-like colonies were obtained from
EGM-2 conditions only. These spheres were dissociated into
single cells by use of trypsin and resuspended in differentiation
media (for osteogenesis, adipogenesis and neurogenesis). For all
induction cultures, cells were maintained for 9 or 13 days before
harvesting for RNA extraction or fixation with 4% paraformal-
dehyde for immunofluorescence.
Table 1. Primers used for studies.
Gene names 5’-Forward-3’ sequences 5’-Reverse-3’ sequences
ADIPOQ TGCCCCAGCAAGTGTAACC TCAGAAACAGGCACACAACTCA
ALPL CCTGGAGCTTCAGAAGCTCA ACTGTG GAGACACCCATCCC
b3-Tubulin ATCCGGACCGCATCATGAAC- ACCATGTTGACGGCCAGCTT
CNN3 GGCTCTAGCAGGTCTGGCTAA AATGTCAATGGTTGTATGGAATCCT
COL2a1 CTGCAAAATAAAATCTCGGTGTTCT GGGCATTTGACTCACACCAGT
DLX2 TTCGGATAGTGAACGGGAAG GAAGCACAAGGTGGAGAAGC
DLX5 GCCACCAACCAGCCAGAGA GCGAGGTACTGAGTCTTCTGAAACC
ELN AACCAGCCTTGCCCGC CCCCAAGCTGCCTGGTG
EMX2 TCCAAGGGAACGACACTAGC TCTTCTCAAAGGCGTGTTCC
GRIA3 ACACCATCAGCATAGGTGGACTT ACGGCAAAGCGGAAAGC
LEP CGGAGAGTACAGTGAGCCAAGA CGGAATCTCGCTCTGTCATCA
MAP2 ACCGGGAGAGGCAGAATTTCCAC AGCGCTTTTCTGGGCTCTTGGT
MEST TCGAGGTCTCACCCCAGTCTT CCACATGTCCCACAGCTCACT
MYOC GGACTGCTCTGGCAACCCAGTGC CATCTGCTGACTCCGGGTCATTTGC
NANOG TGGACACTGGCTGAATCCTTC CGTTGATTAGGCTCCAACCAT
OCT-4 A AGTGAGAGGCAACCTGGAGA GTGAAGTGAGGGCTCCCAT
OPG TTCCGGAAACAGTGAATCAA CGCTGTTTTCACAGAGGTC
OSC GAGGGCAGCGAGGTAGTGAAGA CGATGTGGTCAGCCAACTCG
PPARc2 TCAGGGCTGCCAGTTTCG GCTTTTGGCATACTC TGTGATCTC
PTHR1 ACATCTGCGTCCACATCAGGG CCGTTCACGAGTCTCATTGGTG
RANKL TCCCATCTGGTTCCCATAAA GGTGCTTCCTCCTTTCATCA
RUNX-2 GGCCCACAAATCTCAGATCGTT CACTGGCGCTGCAACAAGAC
SOX2 CCATCCACACTCACGCAAAA TATACAAGGTCCATTCCCCCG
SOX6 CACCAGATATCGACAGAGTGGTCTT CAGGGTTAAAGGCAAAGGGATA
SOX9 CAAGACGCTGGGCAAGCTCT TCTTCACCGACTTCCTCCG
doi:10.1371/journal.pone.0048648.t001
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Figure 1. Mesenchymal stem cell (MSC) characteristics. MSC phenotype of cells cultured with endothelial cell growth medium 2 (EGM-2) and
standard medium for MSCs (MSM). (A, B) Photonic microscopy of morphology of cultured cells, and (C) quantification by flow cytometry of
expression of membrane molecules characterizing bone-marrow MSCs with antibodies against CD markers conjugated with FITC or phycoerythrine.
(D) Alizarin-red, Nile-red and COL2a1 staining for osteoblastic, chondroblastic and adipocytic potential, respectively.
doi:10.1371/journal.pone.0048648.g001
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Quantification of Bipotential CFU-fs
Sorted cell subsets were seeded at 4 to 6 cell concentrations into
96-well plates (12–24 wells/dilution). At day 10, using an inverted
phase microscope colonies of more than 50 cells (CFU-fs) were
counted. Then, CFU-fs from wells were induced to differentiate
into adipocytes or osteoblasts as described. The frequency of
responding cells at any one time was calculated from the
proportion of negative wells by use of the Poisson formula.
Assessment of Functional Potential of Pericytic Cells
Selected cells were cultured with Matrigel (Becton Dickinson,
Franklin Lakes, NJ, USA) overnight before examination under
a photonic microscope. Cultured cells from both conditions were
co-cultured with human umbilical vein endothelial cells (HU-
VECs; Promocell) for 5 days, then stained with anti-von Will-
ebrand Factor (vWF) (Dako, Trappes, France) and anti-aSM actin
antibodies.
Flow Cytometry Studies
Both cell types were examined by flow cytometry. Cells were
washed in phosphate buffered saline/human serum albumin
solution, and the following primary antibodies conjugated to
phytoerythrin (PE) or fluorescein isothiocyanate (FITC) were
added at the appropriate concentrations: stem cell factor receptor
(CD117), CMH-II, and CD105 (Diaclone, Besanc¸on, France);
mouse monoclonal antibody (Mab) anti-human CD34, CD45, and
CD146 (Millipore); Mabs anti-human CD133 (Miltenyi Biotec),
anti-human vascular endothelial growth factor-type 2 receptor
(anti-VEGF-R2), CD49a, CD49b, CD166, CD73, CD44, and
Tie2 (Becton Dickinson); and rabbit polyclonal anti-human
CD144 (VE-cadherin) (Valbiotech, Paris, France). Antibodies of
the same isotype were used as negative controls (Diaclone,
Immunotech, Becton Dickinson and Millipore). Cells were passed
through the Becton Dickinson FACSort (Mountain View, CA)
equipped with the Cellquest software program. The fluorescence
histogram for each monoclonal antibody was displayed with that
of the corresponding control antibody.
After expansion, EGM-2– or MSM-cultured cells were cultured
in chamber slides, and confluent cells were stained with 3G5
antibody (produced from the ATCC cell line and purified by RD-
Biotech, Besanc¸on, France) or by anti-aSM actin (clone 1A4,
Sigma-Aldrich), and then at 37uC for 45 min with FITC-labeled
goat anti-mouse or donkey anti-rabbit secondary antibody
(Invitrogen). After neuronal differention, cells were incubated
with the antibodies anti-Nestin, -AP2a, -p75, -MAP2, -SOX10, -
SLUG and anti-NeuN (see supporting information). Positive cells
were counted and compared to total cell counts for percentage
positive cells.
Real-time RT-PCR
Total RNA was extracted from differentiated and undifferen-
tiated cells and purified with use of the RNAeasy purification kit
(Qiagen, Courtaboeuf, France). Reverse transcription involved the
Takara Kit (St. Germain en Laye, France) in a final volume
containing 1 mg RNA. The reagents in 20 mL PCR included 1 X
SYBR GREEN mix (Biorad, Marnes-la-Coquette, France) and
25 ng cDNA. The primers are in Table 1. All real-time PCR
reactions were performed in duplicate. mRNA expression was
normalized to that of GAPDH.
Western Blot Analysis
Proteins were extracted, separated by 10% Tris-glycine on
SDS-PAGE, and transferred to nitrocellulose membrane (Amer-
sham Biosciences, Saclay, France), then incubated with anti-
OCT4, anti-SOX2 and anti-RUNX2 antibodies (Abcam), 1 mg/
mL, then peroxidase-conjugated mouse anti-rabbit IgG antibody
(Sigma-Aldrich) and visualized by enhanced chemiluminescence
(Thermo Fisher, Courtaboeuf, France). b-actin was an internal
control (Sigma-Aldrich).
Animal Study and Histology
All animal study procedures were performed in accordance with
a protocol approved by the local committee for animal care and
ethics (French ethics committee CEEA.PdL.06 and local veteri-
nary services (license nuC44015)). Macroporous biphasic calcium
phosphate (BCP) ceramic discs, 8 mm in diameter and 3 mm thick
(Biomatlante SA, Vigneux de Bretagne, France), were composed
of 20 hydroxyapatite and 80 wt.% b-tricalcium phosphate and
sterilized by gamma irradiation (total porosity: 70% to 75%;
macroporosity: 400 mm). All experiments involved a minimum of
5 animals per group. In total, 200 mL medium containing 7.56105
human MSCs were seeded onto BCP discs, and after their
absorption, 1 mL medium was added (experiments were repeated
with MSCs from 3 different donors). The cells were cultured in the
tested media for 7 days in low attachment plates, and medium was
refreshed twice weekly. Five samples were used for each condition.
Cultured BCP discs were subcutaneously implanted in the backs
of NMRI nude male mice (Elevage Roger Janvier, Le Genest Saint
Isle, France). A 1-cm-long incision was made on each side of the
mouse back, and blunt dissection was used to separate the skin
from subcutaneous connective tissue to form pockets into which
discs were inserted. The mice were killed after 8 weeks by lethal
intracardiac injection of thiopental, and the implants were
retrieved. The explants were processed according to standard
operating procedures for non-decalcified histology. Samples were
decalcified in EDTA, dehydrated and embedded into paraffin;
100-mm-thick cross sections were obtained by use of a diamond-
saw microtome (Leica SP 1600, Leica Microsystems, Nanterre,
France), stained with hematoxylin or Masson’s trichrome and
analyzed by light microscopy.
The human origin of cells within the transplants was
confirmed by in situ hybridization of human-specific genomic
repetitive sequence as described [19]. A locked nucleic acid
(LNA) probe was designed within the human Alu-Sb2 subfamily
consensus sequence (Genbank no. HSU14570) with the
advanced online design software of Exiqon (Vedbaek, Den-
mark). The LNA-Alu probe was labeled with Digoxigenin (DIG)
at the 59 and 39 ends. Deparaffinized and rehydrated sections
were treated with 1 mg/ml pepsin in 0.1 N HCl at 37uC for
30 min. After a wash with PBS, 70 nM Alu-LNA probe was
Figure 2. Neuronal potential of cells. Photonic microscopy of cells cultured under MSM (A) or EGM-2 conditions (B) with neuron-inducing
medium on days 6 and 13, and fluorescence microscopy of human microtubule-associated protein 2 (hMAP2). After 2 weeks of neurogenic culture,
only MSM culture greatly decreased MSC cell number (A), whereas EGM-2–derived cells still survived and aggregated, forming floating neurosphere-
like structures expressing MAP2 protein (B). (C) Neurosphere-like structures underwent induction of neuronal, adipocytic and osteoblastic
differentiation by culture in appropriate media after their dissociation. Sphere-derived cells re-adhered and Nile-red and Alizarin-red staining showed
adipocytes and osteoblastic cells, respectively. Neurogenic culture induced the expression of neuron-specific markers p75, MAP2, AP2a and Nestin.
Nuclei were stained with DAPI.
doi:10.1371/journal.pone.0048648.g002
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added to tissue sections in 2X SSC (300 mM sodium chloride,
30 mM trisodium citrate, pH 7.4), 50% deionized formamide
and 10% dextran sulfate. Denaturation of DNA was carried out
at 95uC for 5 min, followed by hybridization at 37uC for 2 hr.
After 2X SSC 50% deionized formamide washes, the hybrid-
ization of LNA-Alu probe was revealed with horseradish
peroxydase-conjugated anti-DIG antibody conjugated (1/50e;
Roche Diagnostic France) with use of an AEC staining kit
(Sigma Aldrich). Nuclei were counterstained with hematoxylin
and sections were dehydrated and mounted with Faramount
medium (Dako). Sections of human osteosarcoma in muscle of
nude mouse were positive and negative controls during in situ
hybridization with the LNA-Alu probe.
Statistical Analysis
Data are expressed as mean 6 SEM and were analyzed by
nonparametric Kruskal-Wallis test. Two-sided P,0.05 was
considered statistically significant.
Results
EGM-2-derived Cells are Highly Plastic Progenitors
We split BM mononuclear cells from donors and cultured them
in in vitro medium adapted for pericytes, EGM-2 [20], and
compared results to culture in medium for MSCs, MSM. Culture
in EGM-2 produced CFU-fs. EGM-2- and MSM-cultured cells
did not differ in lag phase before colony appearance, proliferation
or CFU-f number, size or number of bipotential CFU-f (adipocyte
and osteoblastic potentials) (data not shown). As well, EGM-2–
and MSM-cultured cells did not differ in MSC phenotypic
characterization, including morphologic features, membrane
molecules or ability to generate osteoblasts, chondroblasts and
adipocytes (Figure 1). However, when EGM-2-derived cells were
cultured under neurogenic conditions, cells aggregated to form
MAP2+ neurosphere-like structures, which were never observed
with standard MSCs (Figure 2). After their dissociation, the cells
were assessed for adipocyte and osteo-chondroblastic multi-
potentiality. We observed lipid-droplet–containing cells or miner-
alization, although with low efficiency. In addition, after prolonged
neurogenic induction, we observed neuronal cells. Of note, in
contrast to standard MSCs, EGM-2–cultured MSCs showed
a significant increase in commitment toward a neuronal lineage
(Figure 2 & Figure S1).
EGM-2 Culture Consistently Produced a Pericyte
Phenotype
We assessed the perivascular/pericytic phenotype and function
of cells in our in vitro conditions. We characterized pericytes with
anti-aSM actin and -3G5 antibodies, 2 markers used for pericyte
characterization [6]. 3G5 staining was greater for EGM-2– than
MSM-cultured MSCs (Figure 3A, B). Because pericytes can
themselves (and without endothelial cells) form interconnected
networks between them when seeded on basement membrane
proteins found in Matrigel [21,22], we tested this potential after
overnight incubation. As compared with MSM-cultured MSCs,
only EGM-2–cultured cells organized into pericyte-like networks
(Figure 3C, D). As well, when seeded with HUVECs, EGM-2–
cultured cells were organized near HUVECs as aSM actin+ cells
recovering von Willebrand factor+ endothelial cells and forming
structures resembling tubes (Figure 3E). Therefore, EGM-2-
cultured cells exhibited a pericyte phenotype and function that
was more marked than with MSM-cultured MSCs. Surprisingly,
almost all MSM-cultured but only a few EGM-2–cultured PPs
were positive for aSM actin.
We wondered whether the media were capable of modulating
3G5 antigen and aSM actin expression, so we cultured cells in
MSM until confluence and shifted them to EGM-2 and vice versa
(Figure 3F). Whatever the combination after culture in MSM, all
cells remained 3G5dim but aSM actin+. Therefore, the standard
MSC phenotype persisted in MSCs, whatever the culture
conditions used, as compared with EGM-2 cells, which showed
modified expression of 3G5 antigen or aSM actin in MSM culture
and rendered them phenotypically indistinguishable from standard
MSCs. Because the aSM actin molecule is a differentiation-stage–
dependent marker of VSMC lineage, EGM-2-cultured PPs might
be phenotypically more immature than standard MSCs [6].
Therefore, regarding these data EGM-2 derived cells were
hereafter referred to as pericyte progenitors (PPs).
EGM-2-cultured PPs are more Immature than are MSM-
cultured MSCs
Classical MSCs express aSM actin and several lineage markers
because of their differentiation potential [23]. In addition to aSM
actin for the VSMC lineage, osteoblastic, chondroblastic and
adipocytic lineages are revealed by the expression of the molecules
RUNX2, SOX6 and PPARc, respectively [23]. The mRNA
expression of all genes characterizing chondroblasts (COL2A1,
SOX9, SOX6 and DLX2), adipocytes (AdipoQ, LEP), osteoblasts
(ALPL, PTHR1, RUNX2, DLX5 and OSC), and VSM (EMX2,
CNN3, ELN, MYOC) was lower in EGM-2– than MSM-cultured
cells, but the mRNA level of PPARc2 was comparable (Figure 4A).
RUNX2 (a master gene of skeletogenesis) is expressed in BM-
MSCs [1]. Hence, it typifies BM-MSCs as skeletal stem cells (i.e.,
cells generating all BM mesenchymal lineages). We found RUNX2
protein level decreased in EGM-2-cultured PPs, which confirmed
the RT-PCR mRNA results (Figure 4B).
We focused on the molecules NANOG, OCT4 and SOX2 that
are specific to immaturity/stemness characterizing embryonic and
induced pluripotent stem cells (ES and iPS, respectively) [24].
OCT4 has several isoforms, mainly OCT4A and OCT4B, and
only OCT4A contributes to the stemness properties found in ES
and iPS cells [25]. The mRNA expression of OCT4A and SOX2
was greater (2- and 20-fold increase, respectively) in EGM-2– than
MSM-cultured cells (Figure 5A), but the 2 cells types did not differ
in NANOG expression. The protein level of OCT4A was
consistently found in EGM-2 culture but was not or was barely
detected in MSM-cultured MSCs; the protein expression of SOX2
was detected only in EGM-2–cultured PPs (Figure 5B). Further-
more, upregulated OCT4A and SOX2 expression was associated
with decreased RUNX2 expression in EGM-2–cultured PPs,
which was opposite to that in MSM-cultured cells. Therefore, with
the increased protein expression of stemness markers and
Figure 3. Pericyte phenotype and function. Assessment of pericyte phenotype by pericyte-specific 3G5 antibody (A, B) and function by seeding
onto matrigel (C, D, E) in cells cultured with EGM-2 (A, C) or MSM (B, D). Cultured human umbilical vein endothelial cells (HUVECs) were incubated
with anti-von Willebrand factor (vWF) antibody revealing Weibel-Palade bodies (E1). EGM-2–cultured cells were seeded onto HUVECs and incubated
for 5 days and labeled with (E2) anti-a-smooth muscle (SM)-actin and anti-vWF factor antibodies. (F) Proportion of EGM-2– or MSM-cultured cells
(from the same bone-marrow [BM] sample) expressing aSM actin and 3G5 antigen (3G5 Ag) before or after priming into the opposite medium (MSM
or EGM-2, respectively).
doi:10.1371/journal.pone.0048648.g003
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Figure 4. Expression of mesenchymal lineage markers. (A) Quantitative RT-PCR of relative mRNA expression of markers of chondrogenesis
(COL2a1, SOX9, SOX6, DLX2), adipogenesis (PPARc2, ADIPOQ, LEP), osteogenesis (ALPL, PTHR1, RUNX2, DLX5, OSC, OPG, RANKL), and vascular smooth
muscle (VSM) (EMX2, CNN3, ELN,MYOC). Expression was relative to that of GAPDH and depicted as fold change relative to that for pericyte progenitors
(PPs). Data are mean6SEM from 6 experiments. *p,0.01; **p,0.001 compared with PPs. (B) Western blot analysis of protein level of RUNX2 in 3
different BM productions (BM1, BM2, and BM3) of bone-marrow MSCs and PPs. b-actin was a positive internal control.
doi:10.1371/journal.pone.0048648.g004
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Figure 5. Expression of stemness markers. Quantitative RT-PCR (A) and western blot (B) analysis of the mRNA and protein expression,
respectively, of stemness specific markers OCT4A, SOX2 and quantitative RT-PCR analysis of NANOG mRNA expression. Data are mean6SD from 3
experiments. *p,0.01; **p,0.001 compared with PPs. Protein extracts of cells from 3 different BM cultures (BM1, BM2, BM3) of PPs vs MSCs were
tested. b-actin was a positive internal control. ND: not determined. MEL1: protein extract of human embryonic stem cell line MEL1 as positive control.
doi:10.1371/journal.pone.0048648.g005
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concomitant decrease in lineage markers, EGM-2-cultured PPs
were phenotypically more immature than MSM-cultured MSCs.
EGM-2-cultured PPs Show Strong Engraftment Potential
We investigated engraftment capacity in vivo in nude mice. BM
cells were cultured in EGM-2 or MSM and then seeded into bone
substitutes (BCP discs). After adherence, biomaterials were
inserted in mice for 8 weeks. Collagen matrix inside the
biomaterials was greater for discs seeded with EGM-2– than
MSM-cultured cells (Figure 6). Furthermore, discs seeded with
EGM-2–cultured PPs showed cells lining trabecules and engulfed
within extracellular matrix as compared with discs seeded with
MSM-cultured MSCs (Figure 6C). In seeking the human origin of
cells with Alu sequences, we observed numerous human cells with
a mesenchymal appearance only within EGM-2–derived trans-
plants (Figure 7A). In contrast to EGM-2–cultured PPs, few MSM-
cultured MSCs of human origin were detected (48.1%66 vs.
1.860.7 human to host cells, respectively, p,0.001) (Figure 7D
and E). We found 3 types of localizations in EGM-2–derived
transplants: the perivascular position, within the fibrous matrix
and along BCP trabeculae (most). Interestingly, despite their
strong engraftment potential, PPs had significantly lower effective
immunosuppression properties than MSCs in vitro (Figure S2).
Discussion
The abluminal position seems to be the preferential niche for
several types of multipotential cells such as MSCs and PPs,
whatever the tissue of origin. This position allows them to
maximize all of their properties (i.e., organogenesis, tissue renewal
and regeneration post-injury). MSCs and PPs share numerous
properties and are phenotypically similar. Here, we aimed to
compare these 2 types of cells from human BM. In vitro-derived
PPs cultured in EGM-2 showed more plasticity, stronger
expression of stemness markers (immaturity) and more engraft-
ment potential than classically cultured MSCs. Notably, at 8 weeks
post-transplantation in mice, EGM-2–derived PPs showed strong
capacity for collagen matrix formation and were found mainly in
perivascular and trabecular niches.
Despite the strong engrafment potential of PPs in mice, PPs
showed in vitro immunosuppression but at a lower extent than for
MSCs. The reactivity of PPs with immune cells was previously not
investigated and deserves further study.
Phenotypes of BM-derived PPs and MSCs are similar except in
3G5 and aSM actin expression. 3G5 is used to characterize or
select pericytes [6,13]. Despite any comparison between BM
MSCs and BM PPs, 3G5 was also found expressed by MSCs,
although in their native form [26,27]. 3G5 was found in cultured
MSCs, but its expression seems to be downregulated with standard
culture [27]. This finding is in agreement with our results showing
that standard culture conditions (MSM) irreversibly decreased
3G5 antigen expression. Furthermore, such decrease was followed
by induced expression of aSM actin protein.
aSM actin is also widely used as a pericyte and MSC marker
whatever the tissue of origin [28]. Our data showed few cells
positive for aSM actin when expanded in EGM-2. This
discrepancy can be explained by the immaturity of EGM-2
derived cells. Indeed, in VSM differentiation processes, aSM actin
is an early-differentiation stage marker, which implies that more
immature cells do not express it [29,30]. This suggestion was
confirmed recently by several reports showing that pericyte
precursors from iPS or perivascular progenitor cells do not express
aSM actin [31,32]. However, the aSM actin gene promoter
contains the CArG box, a cis-element regulating its expression, as
well as those of the VSMC lineage (e.g., SM22a and CD49a) [33].
The CarG element specifically binds the serum response factor,
which is stimulated by serum [34]. Because serum is in much
higher content in standard medium for MSC expansion (10%
FBS) than in EGM-2 (2% FBS), standard culture conditions are
thus more likely to induce aSM actin expression than EGM-2
medium. Nevertheless, despite the absence of aSM actin
expression, EGM-2-derived PPs could give rise to cells with
pericyte capacities because they can cover endothelial cells and
form a network in Matrigel, even in the absence of endothelial cells
[21,22]. Interestingly, these pericytes became aSM actin+ when
interacting closely with HUVECs in co-cultures, which suggests
their induction from endothelial cells as previously described [35].
Therefore, despite the reduced aSM actin expression (mechanisms
that remain to be clarified), EGM-2–cultured PPs showed pericyte
properties.
The reduced aSM actin expression in PPs suggested that they
were highly immature. This hypothesis was confirmed by the low
expression of a panel of lineage markers concomitant with the
upregulated expression of stemness markers. Indeed, OCT4 and
SOX2 proteins were consistently expressed with EGM-2 culture,
and their expression was opposite to that of the osteoprogenitor
marker RUNX2. This finding agrees with OCT4 and SOX2
being stemness proteins allowing self-renewal of ES cells, with
greatly decreased expression when cells commit to a lineage [36].
The finding is also in line with a recent report demonstrating that
early-passage MSCs, or MSCs with p21 knocked out, showed
upregulated expression of OCT4, SOX2 and NANOG to the
detriment of tissue-specific markers and that knock-down of
OCT4 or NANOG enhanced the expression of the tissue markers
[37]. The authors used 16.6% FBS and hypoxic (1% O2)
conditions for expansion of MSCs. Therefore, the culture
conditions are crucial for the stem-cell potential of MSCs. Here,
we showed that pericyte-specific culture conditions generated PPs
with more immature features that standard MSCs.
Despite the well-known plasticity of standard MSCs, the
immature state of EGM-2–cultured PPs was associated with
greater differentiation potential because they yielded reliable
neuronal differentiation, whereas most MSM-cultured MSCs did
not survive after induction. Interestingly, after induction, EGM-2-
expanded PPs formed aggregates resembling neurospheres con-
sisting of cells capable of generating osteoblasts, adipocytes and
neuronal cells. Cells forming neurospheres can be stem-cell–like
cells [38]. This phenomenon was previously reported for PPs from
post-natal rat aorta and perivascular progenitor cells from human
adult vena saphena, which further demonstrates a similar pheno-
type to the PPs we describe [32,39].
Therefore, as compared with standard culture conditions for
MSCs, culture with EGM-2 selects PPs with broader potentiality,
Figure 6. In vivo investigation of stem/progenitor cell seeding in mice. EGM-2–derived PPs or MSM-derived MSCs were seeded into biphasic
calcium phosphate (BCP) biomaterial discs and inserted in the back of mice (A). Several BCP discs were not loaded with cells as negative controls (B).
After 8 weeks, all discs were removed and evaluated for collagen matrix deposition within transplants and human cell engraftment. Vessels and bone
collagen were observed after hematoxylin (left) or Masson’s trichrome (right) staining, respectively. Dotted black lines indicate the outer border of
discs. Red arrows show vessels, and blue arrows show bone matrix. (C) BCP discs loaded with EGM-2–cultured PPs show trabeculae lined with cells
engulfed within matrix on Masson’s trichrome staining (green fibers).
doi:10.1371/journal.pone.0048648.g006
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Figure 7. In vivo detection of cells of human origin. Alu sequences were checked in cells from microsections of BCP transplants seeded with PPs
cultured with EGM-2 (A–C) or MSCs with MSM (D). (A) Human cells were depicted by red staining in nuclei (arrowheads). (B) and (C) enlargement of
the squared area in (A). Human cells lined BCP trabeculae, formed fibrous tissue, or were at the abluminal position of vessels (B, C). (D) Very few cells
of human origin were detected with seeding of MSM-cultured MSCs. (E) Quantification of human vs host cells involved counting the number of Alu+
nuclei (*p,0.001) in more than 10 fields per transplant and 3 transplants.
doi:10.1371/journal.pone.0048648.g007
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probably because of their immature state. However, we cannot
exclude that BM contains several types of non-hematopoietic
multipotential cells and in vitro conditions could select one type for
their expansion. Nor can we exclude that highly immature non-
hematopoietic multipotential cells can be expanded better under
EGM-2 than standard culture conditions or, in other words,
standard conditions may allow for more restrictive stem-cell
potentials, probably because of proteins in serum. Indeed, we
showed the irreversible gain in aSM-actin expression when cells
were cultured under standard conditions (Figure 3F).
In conclusion, EGM-2 can be used for expansion of highly
immature PPs with strong differentiation and engraftment
capacities. These conditions can also allow for studying BM adult
stem-cell biology and may improve in vitro protocols for clinical
use. However, several questions remaining to be solved include the
origin of EGM-2-derived PPs, their true stemness states, their
complete differentiation capacities and the molecular mechanisms
yielding such properties.
Supporting Information
Figure S1 Neuron differentiation potential of cells
cultured in endothelial growth medium 2 (EGM-2) and
mesenchymal stem cell medium (MSM). (A) Quantitative
RT-PCR analysis of mRNA level of neuronal markers MAP2,
b3Tubulin or b3T, MEST, GRIA3 and (B) in situ immunofluores-
cence (Table) of SLUG, NeuN, MAP2, and SOX10 levels.
Differentiation potentials are at the bottom of the panel. For
neuronal differentiation characterization, cells were fixed and
permeabilized after neuronal induction, then incubated at 37uC
for 1 h with the primary antibody mouse anti-human Nestin
(hNestin) clone 196908, anti-SLUG or anti-SOX10 (R&D
Systems, Lille, France); mouse anti-hNeuN (Sigma-Aldrich);
mouse anti-human microtubule-associated protein 2 (hMAP2)
clone M-9942 (Sigma-Aldrich); rabbit anti-hP75 (nerve growth
factor receptor [NGFR]) (ab-8878, Abcam, Paris); rabbit anti-
hAP2a (Abcam, ab108311) and then at 37uC for 45 min with
FITC-labeled goat anti-mouse or donkey anti-rabbit secondary
antibody (Invitrogen). Positive cells were counted and compared to
total cell counts for percentage positive cells.
(TIF)
Figure S2 Immunosuppression potential assay of PPs
and MSCs. For in vitro immunosuppression assay 506103 cells
cultured in EGM-2 or MSM were co-cultured with 1006103
CD3+ T cells isolated from PBMCs by use of a T-cell purification
kit (Miltenyi Biotec, Bergish Gladbach, Germany). We used 3
donors for MSCs or PPs and 3 donors for PBMCs. Before the co-
cultures, CD3+ cells were labelled with 5-(and-6)-carboxyfluor-
escein diacetate, succinimidyl ester (CFSE, Invitrogen) as fluores-
cent cell-tracing reagent. T cells were then activated with
CD3+CD28+ microbeads (Miltenyi Biotec). After 5 days, all cells
were recovered, and T cells were stained with anti-CD3 and anti-
CD45 antibodies (Miltenyi Biotec). The proportion of cycling
CD3+CD45+ T cells was quantified by fluorescence decrease of
CFSE as compared with both uncycling cells (non-stimulated cells)
and stimulated T cells cultured without MSCs or PPs. Analysis
involved use of the CyanTM flow cytometer (Beckman Coulter,
Villepinte, France) and KaluzaTM software. The percentage of
CD3+ T lymphocytes proliferating during the co-cultures (LyT +
MSCs or LyT + PPs) were calculated. Stimulated T lymphocytes
without MSCs or PPs (LyT) were used as control cells, for 100% of
cycling cells. Data are mean 6 SEM from 3 experiments.
(TIF)
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